| Catalog Number |
00020014600 |
| Medical Device Problem Code |
Improper or Incorrect Procedure or Method (2017)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
04/09/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This is an initial report.A follow-up report will be submitted upon investigation completion.
|
| |
|
Event or Problem Description
|
|
Potentially erroneous result generated due to hit alternative predilution (d) test being ordered instead of the main test using hemosil hit-ab (pf4-h) lot b37012 on acl top 550 cts sn (b)(6).A complaint was submitted on hemosil hit-ab (pf4-h), lot b37012, pn 00020014600, indicating that a laboratory user mistakenly ordered and performed a hit alternative predilution (d) test instead of the standard hit_ab test on (b)(6) 2025.At this time, the impact on the patient remains unknown.
|
| |
|
Additional Manufacturer Narrative
|
|
The certificate of analysis (coa) for hemosil hit-ab (pf4-h), lot: b37012, pn: 00020014600 was reviewed.The reagent met all required specifications, and no abnormalities were identified.Review of the submitted sample result report indicates that an on-board dilution test was performed.The laboratory user mistakenly ordered and performed a hit alternative predilution (d) test instead of the standard hit_ab test.The hit alternative predilution (d) test involves a 1:4 dilution of the patient's plasma.This process can lead to over-dilution of anti-pf4/heparin antibodies, especially in patients who already have a low concentration of these antibodies.To minimize this risk, it is recommended to perform the standard hit_ab test first and only proceed with the diluted test as defined in the werfen-locked test definition.Patient impact is unknown.Based on this assessment, no remedial action is required.This incident will be monitored through trending analysis.
|
| |
|
Search Alerts/Recalls
|